Search

Your search keyword '"Petersen, Ronald"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Petersen, Ronald" Remove constraint Author: "Petersen, Ronald" Database OpenAIRE Remove constraint Database: OpenAIRE
166 results on '"Petersen, Ronald"'

Search Results

1. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

2. Jakob Emanuel Lange: The man and his mushrooms

Catalog

Books, media, physical & digital resources

3. Novel CYP1B1-RMDN2 Alzheimer’s disease locus identified by genome-wide association analysis of cerebral tau deposition on PET

4. Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative

5. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

6. The trend of disruption in the functional brain network topology of Alzheimer’s disease

7. Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (Nature Communications, (2020), 11, 1, (411), 10.1038/s41467-019-13962-0)

8. Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

9. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

10. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

11. AI-ECG for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts

12. FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

13. Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

14. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited

15. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology

16. Additional file 1 of White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition

17. Additional file 1 of Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

18. Jakob Emanuel Lange: The man and his mushrooms

19. Polygenic Scores of Alzheimer’s Dementia Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden

20. Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (Nature Communications, (2020), 11, 1, (2612), 10.1038/s41467-020-15701-2)

21. Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease

22. Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status

23. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

24. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

25. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia: Implications for therapeutic strategy

26. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

27. Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

28. Plasma and CSF neurofilament light

29. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

30. Four distinct trajectories of tau deposition identified in Alzheimer’s disease

31. Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers

32. Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2

33. Lack of physical activity, neuropsychiatric symptoms and the risk of incident mild cognitive impairment in older community-dwelling individuals – A prospective cohort study

34. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

35. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease

36. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

37. A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease

38. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

39. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

40. Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology

41. Additional file 1 of Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy

42. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

43. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

44. Additional file 3 of Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

45. The genetic architecture of the human cerebral cortex

46. Additional file 1 of Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

47. How early can we diagnose Alzheimer disease (and is it sufficient)?

48. Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements

49. A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

50. Predicting Alzheimer’s disease progression using multi-modal deep learning approach